1-20 of 28
Authors: Alexander Niessner
Save search
Sort by
Journal Article

Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis

PDF
Paul M Haller and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 5, August 2024, Pages 444–453, https://doi.org/10.1093/ehjcvp/pvae042
Published: 06 June 2024
Journal Article
EDITOR'S CHOICE

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023

PDF
Juan Tamargo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 10, Issue 3, April 2024, Pages 219–244, https://doi.org/10.1093/ehjcvp/pvae013
Published: 20 February 2024
Journal Article

New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2022

PDF
Juan Tamargo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 4, June 2023, Pages 353–370, https://doi.org/10.1093/ehjcvp/pvad034
Published: 11 May 2023
Journal Article

Prescribing trends of sodium–glucose cotransporter 2 inhibitors in patients with heart failure with preserved, mildly reduced and reduced ejection fraction

PDF
Felix Hofer and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 9, Issue 6, September 2023, Pages 505–506, https://doi.org/10.1093/ehjcvp/pvad022
Published: 24 March 2023
Journal Article

Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

PDF
Juan Tamargo and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 4, July 2022, Pages 406–419, https://doi.org/10.1093/ehjcvp/pvac005
Published: 29 January 2022
Journal Article
EDITOR'S CHOICE

Challenges in cardiovascular pharmacogenomics implementation: a viewpoint from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

PDF
Emma F Magavern and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 1, January 2022, Pages 100–103, https://doi.org/10.1093/ehjcvp/pvab063
Published: 31 August 2021
Journal Article

Dosage of direct oral anticoagulants during dual and triple antithrombotic therapy: a focus on the net clinical benefit

PDF
Niema Kazem and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 5, September 2021, Pages e83–e84, https://doi.org/10.1093/ehjcvp/pvab058
Published: 04 August 2021
Journal Article

Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy

PDF
Heinz Drexel and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 3, May 2022, Pages 302–310, https://doi.org/10.1093/ehjcvp/pvab048
Published: 28 June 2021
Journal Article
EDITOR'S CHOICE

Update on management of hypokalaemia and goals for the lower potassium level in patients with cardiovascular disease: a review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

PDF
Maria Lukács Krogager and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 6, November 2021, Pages 557–567, https://doi.org/10.1093/ehjcvp/pvab038
Published: 06 May 2021
Journal Article

The role of pharmacogenomics in contemporary cardiovascular therapy: a position statement from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy

PDF
Emma Forton Magavern and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 1, January 2022, Pages 85–99, https://doi.org/10.1093/ehjcvp/pvab018
Published: 26 February 2021
Journal Article

The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid, diabetes, and antithrombotic trials

PDF
Heinz Drexel and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 5, September 2021, Pages 453–459, https://doi.org/10.1093/ehjcvp/pvaa126
Published: 02 November 2020
Journal Article
EDITOR'S CHOICE

Potentially inappropriate prescriptions in heart failure with reduced ejection fraction: ESC position statement on heart failure with reduced ejection fraction-specific inappropriate prescribing

PDF
Seif El Hadidi and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 2, March 2022, Pages 187–210, https://doi.org/10.1093/ehjcvp/pvaa108
Published: 17 September 2020
Journal Article

Long-term prognosis of de novo atrial fibrillation during acute myocardial infarction: the impact of anti-thrombotic treatment strategies

PDF
Felix Hofer and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 7, Issue 3, May 2021, Pages 189–195, https://doi.org/10.1093/ehjcvp/pvaa027
Published: 14 April 2020
Journal Article

Prasugrel vs. ticagrelor after acute coronary syndrome: a critical appraisal of the ISAR-REACT 5 trial

PDF
Patrick Sulzgruber and Alexander Niessner
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 5, September 2020, Pages 273–274, https://doi.org/10.1093/ehjcvp/pvz077
Published: 22 December 2019
Journal Article

The age of randomized clinical trials: three important aspects of randomized clinical trials in cardiovascular pharmacotherapy with examples from lipid and diabetes trials

PDF
Heinz Drexel and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 2, March 2020, Pages 97–103, https://doi.org/10.1093/ehjcvp/pvz029
Published: 29 August 2019
Journal Article

Response to: Current opinion of the ESC Working Group on Cardiovascular Pharmacotherapy and ESC Council on Stroke

PDF
Patrick Sulzgruber and Alexander Niessner
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 4, July 2020, Pages 267–268, https://doi.org/10.1093/ehjcvp/pvz040
Published: 26 August 2019
Journal Article

Lipid management in rheumatoid arthritis: a position paper of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology

PDF
Ivana Hollan and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 2, March 2020, Pages 104–114, https://doi.org/10.1093/ehjcvp/pvz033
Published: 09 August 2019
Journal Article
EDITOR'S CHOICE

Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases

PDF
Gianluigi Savarese and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 6, Issue 2, March 2020, Pages 86–93, https://doi.org/10.1093/ehjcvp/pvz036
Published: 08 August 2019
Journal Article

Critical appraisal of the AUGUSTUS trial

PDF
Thomas Gremmel and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 4, October 2019, Pages 187–188, https://doi.org/10.1093/ehjcvp/pvz017
Published: 02 July 2019
Journal Article
EDITOR'S CHOICE

Bleeding and ischaemic outcomes in patients treated with dual or triple antithrombotic therapy: systematic review and meta-analysis

PDF
Paul M Haller and others
European Heart Journal - Cardiovascular Pharmacotherapy, Volume 5, Issue 4, October 2019, Pages 226–236, https://doi.org/10.1093/ehjcvp/pvz021
Published: 14 June 2019